Acquiring Company
Indivior Pharmaceuticals
Acquired Company
Supernus Pharmaceuticals
Greater London
RockvilleBiotechnologyHealth CareMedicalPharmaceuticalBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
On November 2, 2026, Indivior Pharmaceuticals announced the completion of its merger with Supernus Pharmaceuticals. Following the merger, the certificate of incorporation and bylaws of Supernus were amended and restated. This acquisition is aimed at enhancing Indivior's capabilities in addressing addiction and related health issues.
Who to call at Indivior Pharmaceuticals, and when
When Indivior Pharmaceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Indivior Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Indivior Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Indivior Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Indivior Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Supernus Pharmaceuticals?
Supernus Pharmaceuticals was acquired by Indivior Pharmaceuticals, based in Greater London. The deal was reported on November 2, 2026. Indivior Pharmaceuticals, Inc. specializes in the treatment of addiction and is engaged in developing medicines to help individuals with substance use disorders. Indivior Pharmaceuticals is publicly traded (INDV) and operates in Biotechnology.
When did Indivior Pharmaceuticals acquire Supernus Pharmaceuticals?
Indivior Pharmaceuticals's acquisition of Supernus Pharmaceuticals was reported on November 2, 2026. On November 2, 2026, Indivior Pharmaceuticals announced the completion of its merger with Supernus Pharmaceuticals. Following the merger, the certificate of incorporation and bylaws of Supernus were amended and restated. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Supernus Pharmaceuticals do?
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing and commercializing products for the treatment of central nervous system (CNS) diseases. It is publicly traded (SUPN), operating in Biotechnology, and is based in Rockville.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.